Steffi Hartmann

8PUBLICATIONS
34CO-AUTHORS
Immunogenetics (incl. genetic immunology)Predictive and prognostic markersCancer diagnosisRadiation therapyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Oct 16, 2024
Idiopathic Granulomatous Mastitis as a Benign Condition Mimicking Inflammatory Breast Cancer: Current Status, Knowledge Gaps and Rationale for the GRAMAREG Study (EUBREAST-15).

Natalia Krawczyk, Thorsten Kühn, Nina Ditsch

|Sep 08, 2023
Applicability of magnetic seeds for target lymph node biopsy after neoadjuvant chemotherapy in initially node-positive breast cancer patients: data from the AXSANA study.

Steffi Hartmann, Maggie Banys-Paluchowski, Elmar Stickeler

|Feb 25, 2023
Localization Techniques for Non-Palpable Breast Lesions: Current Status, Knowledge Gaps, and Rationale for the MELODY Study (EUBREAST-4/iBRA-NET, NCT 05559411).

Maggie Banys-Paluchowski, Thorsten Kühn, Yazan Masannat

|Aug 10, 2022
Radiopaque tissue transfer and X-ray system versus standard specimen radiography for intraoperative margin assessment in breast-conserving surgery: randomized clinical trial.

Angrit Stachs, Julia Bollmann, Annett Martin

|May 28, 2022
Radiological Underestimation of Tumor Size as a Relevant Risk Factor for Positive Margin Rate in Breast-Conserving Therapy of Pure Ductal Carcinoma In Situ (DCIS).

Gesche Schultek, Bernd Gerber, Toralf Reimer

|Jun 02, 2021
The Clinical Relevance of Target Lymph Node Biopsy after Primary Systemic Therapy in Initially Node-Positive Breast Cancer Patients.

Steffi Hartmann, Angrit Stachs, Gesche Schultek

Pageof 2

Frequent Collaborators

4 joint publications

Jana de Boniface

4 joint publications

Oreste Gentilini

2 joint publications

Hans-Christian Kolberg

2 joint publications

Dawid Murawa